Lateral internal sphincterotomy (LIS) is a minimally invasive procedure used to treat chronic anal fissures. It involves cutting the internal sphincter muscle, which is located between the rectum and the anus. This procedure is used to reduce spasm and pain, as well as to promote healing of the fissure. While it is an effective treatment option, it is not without risks. This article will explore the benefits and risks of LIS in order to help doctors better understand this procedure and its potential impact on their patients.
Lateral internal sphincterotomy (LIS) is a surgical procedure used to treat chronic anal fissures. It involves cutting the internal sphincter muscle, which is located between the rectum and the anus. This procedure is used to reduce spasm and pain, as well as to promote healing of the fissure. The procedure is typically performed under general anesthesia. During the procedure, the surgeon makes a small incision in the sphincter muscle and then divides it in two. This reduces the tension in the muscle, which helps to reduce spasm and pain, as well as to promote healing of the fissure. The procedure is typically performed as an outpatient procedure and takes about 30 minutes to complete. After the procedure, patients typically experience some pain, bleeding, and swelling for a few days.
Lateral internal sphincterotomy is an effective treatment option for chronic anal fissures. The procedure helps to reduce spasm and pain, as well as to promote healing of the fissure. It is also a minimally invasive procedure, which means that it has a shorter recovery time and fewer risks than more invasive surgical procedures. The procedure is also relatively safe. The risks associated with the procedure are typically minor and include pain, bleeding, infection, and swelling. The procedure is also relatively cost-effective, as it is typically performed as an outpatient procedure.
Although the procedure is relatively safe, there are some risks associated with LIS. These risks include pain, bleeding, infection, and swelling. In rare cases, the procedure can also cause damage to the nerves or muscles in the area, which can lead to incontinence or other complications. Additionally, the procedure can cause scarring, which can lead to narrowing of the anal canal.
Lateral internal sphincterotomy is a minimally invasive procedure used to treat chronic anal fissures. The procedure is effective in reducing spasm and pain, as well as promoting healing of the fissure. It is also relatively safe and cost-effective. However, there are some risks associated with the procedure, including pain, bleeding, infection, swelling, nerve or muscle damage, and scarring. Doctors should weigh the risks and benefits of LIS when considering this procedure for their patients.
1.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
2.
Investigating the Relationship Between GERD and Anxiety/Depression.
3.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
4.
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
5.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
1.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
2.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
3.
Vaccines that can help prevent cancer
4.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
5.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation